Banc of America Starts ImClone with Buy

Analyst Michael King thinks ImClone's cancer drug will experience a robust product launch

Banc of America initiated coverage of ImClone Systems (IMCL ) with buy.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.